- Home
- NEON vs AUTL Comparison
NEON vs AUTL Comparison
Compare NEON & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEON
- AUTL
- Stock Information
- Founded
- NEON 1997
- AUTL 2014
- Country
- NEON Sweden
- AUTL United Kingdom
- Employees
- NEON N/A
- AUTL N/A
- Industry
- NEON Industrial Machinery/Components
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEON Technology
- AUTL Health Care
- Exchange
- NEON Nasdaq
- AUTL Nasdaq
- Market Cap
- NEON 428.0M
- AUTL 415.2M
- IPO Year
- NEON 2007
- AUTL 2018
- Fundamental
- Price
- NEON $3.72
- AUTL $1.52
- Analyst Decision
- NEON Hold
- AUTL Strong Buy
- Analyst Count
- NEON 1
- AUTL 5
- Target Price
- NEON $6.00
- AUTL $9.12
- AVG Volume (30 Days)
- NEON 1.6M
- AUTL 4.9M
- Earning Date
- NEON 11-05-2025
- AUTL 11-11-2025
- Dividend Yield
- NEON N/A
- AUTL N/A
- EPS Growth
- NEON N/A
- AUTL N/A
- EPS
- NEON N/A
- AUTL N/A
- Revenue
- NEON $2,605,000.00
- AUTL $29,934,000.00
- Revenue This Year
- NEON N/A
- AUTL $641.63
- Revenue Next Year
- NEON $43.34
- AUTL $109.21
- P/E Ratio
- NEON N/A
- AUTL N/A
- Revenue Growth
- NEON N/A
- AUTL 185.17
- 52 Week Low
- NEON $3.24
- AUTL $1.11
- 52 Week High
- NEON $29.90
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- NEON 23.85
- AUTL 47.85
- Support Level
- NEON $3.24
- AUTL $1.56
- Resistance Level
- NEON $3.93
- AUTL $1.65
- Average True Range (ATR)
- NEON 0.26
- AUTL 0.10
- MACD
- NEON 0.55
- AUTL 0.04
- Stochastic Oscillator
- NEON 39.50
- AUTL 60.80
About NEON Neonode Inc.
Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.